A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a "2+1"Sequential Schedule With bOPV in Infants

clinical trial

Details

Instance of: clinical trial
Start time: 12 June 2018
End time: 20 September 2018
Main subject: safety, poliomyelitis
clinical trial phase: phase III clinical trial
number of participants: 240
research subject recruitment status: completed
study type: interventional study
title: A Randomized, Double-blind, Controlled Clinical Trial to Evaluate the Immunogenicity and Safety of Sabin Inactivated Poliovirus Vaccine (Vero Cell) in a '2+1'Sequential Schedule With Bivalent Oral Poliovirus Vaccine in 2-month-old Infants

Nothing in the MetaHistoryBook collection references this item yet.